Correlation Between Maravai Lifesciences and Evaxion Biotech
Can any of the company-specific risk be diversified away by investing in both Maravai Lifesciences and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maravai Lifesciences and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maravai Lifesciences Holdings and Evaxion Biotech AS, you can compare the effects of market volatilities on Maravai Lifesciences and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maravai Lifesciences with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maravai Lifesciences and Evaxion Biotech.
Diversification Opportunities for Maravai Lifesciences and Evaxion Biotech
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Maravai and Evaxion is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Maravai Lifesciences Holdings and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Maravai Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maravai Lifesciences Holdings are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Maravai Lifesciences i.e., Maravai Lifesciences and Evaxion Biotech go up and down completely randomly.
Pair Corralation between Maravai Lifesciences and Evaxion Biotech
Given the investment horizon of 90 days Maravai Lifesciences Holdings is expected to generate 0.61 times more return on investment than Evaxion Biotech. However, Maravai Lifesciences Holdings is 1.64 times less risky than Evaxion Biotech. It trades about 0.04 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.03 per unit of risk. If you would invest 493.00 in Maravai Lifesciences Holdings on September 14, 2024 and sell it today you would earn a total of 74.00 from holding Maravai Lifesciences Holdings or generate 15.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Maravai Lifesciences Holdings vs. Evaxion Biotech AS
Performance |
Timeline |
Maravai Lifesciences |
Evaxion Biotech AS |
Maravai Lifesciences and Evaxion Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Maravai Lifesciences and Evaxion Biotech
The main advantage of trading using opposite Maravai Lifesciences and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maravai Lifesciences position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.Maravai Lifesciences vs. Roivant Sciences | Maravai Lifesciences vs. Krystal Biotech | Maravai Lifesciences vs. Akero Therapeutics | Maravai Lifesciences vs. Apellis Pharmaceuticals |
Evaxion Biotech vs. Reviva Pharmaceuticals Holdings | Evaxion Biotech vs. ZyVersa Therapeutics | Evaxion Biotech vs. Unicycive Therapeutics | Evaxion Biotech vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements |